Gicquel Stéphanie, Marion-Gallois Roland
Effi-Stat, 15 rue du Louvre, F-75001 Paris, France.
Stat Med. 2007 Nov 30;26(27):5033-45. doi: 10.1002/sim.2953.
The use of randomization for assigning patients to treatment groups in clinical trials is firmly acknowledged as providing the best quality results. Two standard methods are used in order to achieve well-balanced groups with respect to prognostic factors (i.e. factors influencing the disease outcome): stratification and minimization. Stratification is recommended when the number of strata is not too high--otherwise, minimization is preferred. However, minimization may compromise blinding (since the search for balance is performed a priori) and, furthermore, use of the technique has been questioned by the European Agency for the Evaluation of Medicinal Products. We have developed a new procedure for adaptive randomization, which we have named 'randomization with a posteriori constraints'. By using a search for balance a posteriori, this procedure ensures that patient groups are similar with respect to prognostic factors while being less vulnerable to selection bias. The aim of this work was to describe the new method and to compare it (using simulations) with stratification and minimization. In the case of trials with few prognostic factors, the recourse to minimization or 'randomization with a posteriori constraints' does not appear to be useful. In such a context, stratification has suitable properties and its simplicity of implementation encourages its use. However, when the number of prognostic factors is higher, 'randomization with a posteriori constraints' is less predictable than minimization and the chance of imbalance is lower than for stratification. In conclusion, 'randomization with a posteriori constraints' with an adequate threshold seems to be a good compromise between minimization and stratification.
在临床试验中使用随机化将患者分配到治疗组,已被公认为能提供质量最佳的结果。为了在预后因素(即影响疾病结果的因素)方面实现组间良好平衡,使用了两种标准方法:分层和最小化。当分层数量不太多时,推荐使用分层法——否则,更倾向于使用最小化法。然而,最小化法可能会损害盲法(因为平衡搜索是事先进行的),此外,欧洲药品评估局对该技术的使用提出了质疑。我们开发了一种新的适应性随机化程序,我们将其命名为“具有事后约束的随机化”。通过事后搜索平衡,该程序确保患者组在预后因素方面相似,同时更不易受到选择偏倚的影响。这项工作的目的是描述这种新方法,并(通过模拟)将其与分层法和最小化法进行比较。在预后因素较少的试验中,采用最小化法或“具有事后约束的随机化”似乎并无益处。在这种情况下,分层法具有合适的特性,其实施的简单性促使人们使用它。然而,当预后因素数量较多时,“具有事后约束的随机化”比最小化法更难预测,且失衡的可能性比分层法更低。总之,具有适当阈值的“具有事后约束的随机化”似乎是最小化法和分层法之间的良好折衷。